Delineation and characterization of human B cell subpopulations at various stages of activation by using a B cell-specific monoclonal antibody.
Open Access
- 1 June 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 136 (11) , 4027-4034
- https://doi.org/10.4049/jimmunol.136.11.4027
Abstract
Human tonsillar B cells were separated into three distinct subpopulations, Ba-/IgD+, Ba+/IgD+, and Ba+/IgD-, by using a B cell-specific monoclonal antibody (anti-Ba) that recognizes only activated B cells, and anti-IgD antibody. Stimulation of Ba-/IgD+ cells with anti-mu plus PHA-conditioned culture supernatant (PHA-sup) or TPA induced Ba+/IgD+ cells, which reverted to Ba-/IgD+ phenotype in the absence of continuous stimulation. Further stimulation of Ba+/IgD+ cells with several B cell activators, such as TPA plus anti-mu or PWM plus T cells, resulted in the loss of IgD expression. Three-color FACS analysis showed that the expression of transferrin receptor (TFR) was at its maximum in Ba+/IgD- cells, and the intensity of this expression was proportional to that of Ba expression in Ba+/IgD+ cells. PHA-sup induced maximum proliferation in Ba+/IgD- cells, and the degree of response was a function of the intensity of Ba expression in Ba+/IgD+ cells. PHA-sup or purified BCDF (BSF-2) induced Ig secretion preferentially in Ba+/IgD- cells. Taken together, these results show that resting B cells (Ba-/IgD+) are activated into Ba+/IgD+ cells, and then into Ba+/IgD- cells, under mitogenic stimulation, and BCDF induces the final maturation of Ba+/IgD- cells into Ig-secreting cells. Ba+/IgD- cells, which maximally expressed TFR as well as Ba and displayed maximum proliferative response to PHA-sup, did not express any Tac antigen. On the other hand, in vitro activated B cells expressed Ba and TFR as well as Tac antigen.This publication has 27 references indexed in Scilit:
- Proliferation and differentiation of single hapten-specific B lymphocytes is promoted by T-cell factor(s) distinct from T-cell growth factor.Proceedings of the National Academy of Sciences, 1982
- Proliferative responses of normal human B lymphocytes. Development of an assay system for human B cell growth factor (BCGF).The Journal of Immunology, 1982
- Separate signals for human B cell proliferation and differentiation in response to Staphylococcus aureus: evidence for a two-signal model of B cell activation.The Journal of Immunology, 1982
- Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors.The Journal of Immunology, 1982
- Identification of a T cell-derived b cell growth factor distinct from interleukin 2.The Journal of Experimental Medicine, 1982
- T cell-replacing factor- (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF.The Journal of Immunology, 1981
- Expression of cell surface markers after human B lymphocyte activation.Proceedings of the National Academy of Sciences, 1981
- Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes.The Journal of Immunology, 1981
- Loss of surface IgD by human B lymphocytes during polyclonal activation*European Journal of Immunology, 1977
- Conjugation of antibodies with fluorochromes: Modifications to the standard methodsJournal of Immunological Methods, 1976